Market Closed -
NSE India S.E.
05:13:53 24/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
485.8
INR
|
-2.11%
|
|
-3.33%
|
-10.27%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,362
|
3,570
|
3,702
|
4,107
|
8,005
|
9,264
|
EBITDA
1 |
321.9
|
400.6
|
476.6
|
541.4
|
956.1
|
1,148
|
EBIT
1 |
210.7
|
293.9
|
376.9
|
489.4
|
885.7
|
1,047
|
Operating Margin
|
8.92%
|
8.23%
|
10.18%
|
11.92%
|
11.06%
|
11.3%
|
Earnings before Tax (EBT)
1 |
161.7
|
240.3
|
345.5
|
463.4
|
857.2
|
918
|
Net income
1 |
119.4
|
191.8
|
258.6
|
345
|
639.5
|
679.5
|
Net margin
|
5.05%
|
5.37%
|
6.99%
|
8.4%
|
7.99%
|
7.34%
|
EPS
2 |
2.487
|
3.996
|
5.388
|
7.188
|
13.32
|
14.16
|
Free Cash Flow
|
-
|
9.449
|
159.7
|
160.8
|
-1,456
|
-587.2
|
FCF margin
|
-
|
0.26%
|
4.32%
|
3.91%
|
-18.18%
|
-6.34%
|
FCF Conversion (EBITDA)
|
-
|
2.36%
|
33.51%
|
29.69%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
4.93%
|
61.76%
|
46.6%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
02/09/19
|
02/09/19
|
25/11/20
|
30/11/21
|
30/09/22
|
13/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
758
|
705
|
499
|
407
|
1,983
|
2,299
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.354
x
|
1.76
x
|
1.048
x
|
0.7518
x
|
2.074
x
|
2.002
x
|
Free Cash Flow
|
-
|
9.45
|
160
|
161
|
-1,456
|
-587
|
ROE (net income / shareholders' equity)
|
-
|
26.5%
|
27.2%
|
27%
|
36.2%
|
27.6%
|
ROA (Net income/ Total Assets)
|
-
|
8.54%
|
10.1%
|
9.95%
|
11.7%
|
10.2%
|
Assets
1 |
-
|
2,246
|
2,561
|
3,466
|
5,460
|
6,644
|
Book Value Per Share
2 |
13.00
|
17.10
|
22.50
|
30.20
|
43.50
|
57.60
|
Cash Flow per Share
2 |
0.0400
|
0.1700
|
0.5400
|
1.000
|
0.0300
|
0.7300
|
Capex
1 |
147
|
86.4
|
41
|
187
|
799
|
790
|
Capex / Sales
|
6.24%
|
2.42%
|
1.11%
|
4.56%
|
9.98%
|
8.53%
|
Announcement Date
|
02/09/19
|
02/09/19
|
25/11/20
|
30/11/21
|
30/09/22
|
13/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -10.27% | 335M | | +38.51% | 727B | | +33.05% | 599B | | -6.23% | 354B | | +18.78% | 328B | | +1.35% | 277B | | +16.00% | 243B | | +8.09% | 205B | | -5.77% | 203B | | +6.19% | 164B |
Other Pharmaceuticals
|